Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Sino Biopharmaceutical Limited    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED

(1177)
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
07/15/2019 07/16/2019 07/17/2019 07/18/2019 07/19/2019 Date
8.99 8.93 8.87 8.83 9 Last
106127039 66186069 23227039 19671106 37268949 Volume
+5.52% -0.67% -0.67% -0.45% +1.93% Change
Financials (HKD)
Sales 2019 26 968 M
EBIT 2019 6 030 M
Net income 2019 3 631 M
Finance 2019 5 085 M
Yield 2019 0,76%
Sales 2020 30 594 M
EBIT 2020 6 964 M
Net income 2020 4 224 M
Finance 2020 11 007 M
Yield 2020 0,80%
P/E ratio 2019 31,2x
P/E ratio 2020 27,0x
EV / Sales2019 4,00x
EV / Sales2020 3,33x
Capitalization 113 B
More Financials
Company
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of... 
Sector
Pharmaceuticals
Calendar
08/21Earnings Release
More about the company
Surperformance© ratings of Sino Biopharmaceutical Lim
Trading Rating : Investor Rating :
More Ratings
Latest news on SINO BIOPHARMACEUTICAL LIM
07/04ASIA MARKETS: Asian Markets Mixed After Wall Street's Record Highs
DJ
06/27KAROLINSKA DEVELOPMENT : Announcement of the final terms and conditions of Karol..
AQ
06/18SINO BIOPHARMACEUTICAL : Biopharm to set up JV for antibody business
AQ
06/14SINO BIOPHARMACEUTICAL LIMITED : Ex-dividend day for quarterly dividend
FA
06/14SINO BIOPHARMACEUTICAL LIMITED : Ex-dividend day for final dividend
FA
05/22SINO BIOPHARMACEUTICAL : Biopharm 1Q net up 11.1% to RMB856.7 million
AQ
05/21SINO BIOPHARMACEUTICAL : Announces 2019 First Quarterly Results
AQ
05/20ASIA MARKETS: Asian Markets Mixed As Investors Weigh Huawei Implications
DJ
05/10SINO BIOPHARMACEUTICAL : Biopharm gets drug registration approval
AQ
04/25SINO BIOPHARMACEUTICAL : Biopharm Fudosteine tablet passes evaluation
AQ
More news
Analyst Recommendations on SINO BIOPHARMACEUTICAL LIM
More recommendations
Sector news : Pharmaceuticals - NEC
02:48aJOHNSON & JOHNSON : J&J Fights To Restrict Talc-Suit Testimony
DJ
07/21JOHNSON & JOHNSON : Faces Key Test in Defense Against Talc-Safety Lawsuits
DJ
07/19CELGENE : Says FDA Approves Otezla for Oral Ulcers in Behcet's Disease
DJ
07/19ALLERGAN : Form 8.3 -
DJ
07/19Gilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis
DJ
More sector news : Pharmaceuticals - NEC
Chart SINO BIOPHARMACEUTICAL LIMITED
Duration : Period :
Sino Biopharmaceutical Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINO BIOPHARMACEUTICAL LIM
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 9,16  HKD
Last Close Price 9,00  HKD
Spread / Highest target 46,7%
Spread / Average Target 1,83%
Spread / Lowest Target -46,7%
EPS Revisions
Managers
NameTitle
Ping Tse Chief Executive Officer & Executive Director
Y Y Tse Chairman
Hsuan Tse General Manager-Information Management
Wei Nong Ye General Manager-Research & Development
Hsin Tse Executive Director & Vice President
Sector and Competitors
1st jan.Capitalization (M$)
SINO BIOPHARMACEUTICAL LIMITED74.08%14 471
JOHNSON & JOHNSON0.98%345 980
PFIZER-2.02%237 451
ROCHE HOLDING LTD.11.42%230 263
ROCHE HOLDING13.37%230 263
NOVARTIS24.46%216 273